CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.
Storci G, De Felice F, Ricci F, Santi S, Messelodi D, Bertuccio SN, Laprovitera N, Dicataldo M, Rossini L, De Matteis S, Casadei B, Vaglio F, Ursi M, Barbato F, Roberto M, Guarino M, Asioli GM, Arpinati M, Cortelli P, Maffini E, Tomassini E, Tassoni M, Cavallo C, Iannotta F, Naddeo M, Tazzari PL, Dan E, Pellegrini C, Guadagnuolo S, Carella M, Sinigaglia B, Pirazzini C, Severi C, Garagnani P, Kwiatkowska KM, Ferracin M, Zinzani PL, Bonafè M, Bonifazi F.
Storci G, et al. Among authors: messelodi d.
J Clin Invest. 2024 Jun 4;134(14):e173096. doi: 10.1172/JCI173096.
J Clin Invest. 2024.
PMID: 38833312
Free PMC article.
Clinical Trial.